As noted above, RUNX3 was part of a poor prognostic stromal gene signature in breast cancer patients [152], and very recently, RUNX1 (and also RUNX2) was identified through an epigenetic analysis of murine mammary tumors to be highly upregulated in cancer-associated fibroblasts [189]. This evidence concerns the gene RUNX2 and cancer.